| Literature DB >> 27059426 |
Feiran Li1, Tae-Gon Cha1, Jing Pan1, Altug Ozcelikkale1, Bumsoo Han1, Jong Hyun Choi2.
Abstract
We demonstrate a DNAzyme-based walker system as a controlled oligonucleotide drug AS1411 release platform for breast cancer treatment. In this system, AS1411 strands are released from fuel strands as a walker moves along its carbon nanotube track. The release rate and amount of anticancer oligonucleotides are controlled by the walker operation. With a walker system embedded within the collagen extracellular matrix, we show that this drug release system can be used for in situ cancer cell growth inhibition.Entities:
Keywords: DNA walker; DNAzyme; anticancer; growth inhibition; oligonucleotides
Mesh:
Substances:
Year: 2016 PMID: 27059426 PMCID: PMC5051347 DOI: 10.1002/cbic.201600052
Source DB: PubMed Journal: Chembiochem ISSN: 1439-4227 Impact factor: 3.164